JezK

Edit File: 1574766572.M920758P977091.mocha3025.mochahost.com,S=15110,W=15362:2,S

Envelope-to: dr.tokhi@jack.ngo,
 dr.zia@jack.ngo,
 ghaznawi@jack.ngo,
 mirzaee@jack.ngo,
 takal@jack.ngo,
 ahmad@jack.ngo
Delivery-date: Tue, 26 Nov 2019 06:09:32 -0500
MIME-Version: 1.0
References: <CAPkiFa2M1LuXRSqEb+5f-KFKVuA9cJ5ExvwEoOQtCNzf0JgA5w@mail.gmail.com>
In-Reply-To: <CAPkiFa2M1LuXRSqEb+5f-KFKVuA9cJ5ExvwEoOQtCNzf0JgA5w@mail.gmail.com>
From: "Dr.Nasir Ahmad tokhi" <nasir.tokhi123@gmail.com>
Date: Tue, 26 Nov 2019 15:37:01 +0430
Message-ID: <CAJX2XaK_jDptwTneTPLuJCu5xxxRH+Ep=N=o5fLouGmOC23XqQ@mail.gmail.com>
Subject: Re: ANTI-LASHMANIASIS PRODUCT REQUEST FORM FROM kdz JACK OFFICE
To: Khairullah Naderi <khairullahnaderi@gmail.com>, 
	"Dr.Hafizullah Khalilzoey" <dr_hafizullah@yahoo.com>
Cc: "Dr. Nasir Ahmad Tokhi" <dr.tokhi@jack.af>, dr.tokhi@jack.ngo, dr.zia@jack.ngo, 
	haroon.mahmoodi@jack.af, 
	Mohammad Haroon Mahmoodi <jack.kdz.pharmacy@gmail.com>, ghaznawi@jack.ngo, mirzaee@jack.ngo, 
	Mirzaee@jack.af, Sardar Wali Takal <takal@jack.ngo>, =?UTF-8?Q?=E2=80=8BNoor_Ahmad?= <ahmad@jack.ngo>, 
	sultan rasoolzai <sultanrasoolzai@gmail.com>, fraidon@jack.af
Content-Type: multipart/related; boundary="000000000000c2627805983de1bc"

--000000000000c2627805983de1bc
Content-Type: multipart/alternative; boundary="000000000000c2627605983de1bb"

--000000000000c2627605983de1bb
Content-Type: text/plain; charset="UTF-8"

Dear Khairullah Naderi
Thank you for you request below point is import to be clear .
1. clarify the closing balance of Anti Malaria Vial/Amp in the last month
of  the year health facilities wise and stock buffer ?
2.Number of Supplied of Anti Leishmania Vial/Amp (new supplied)
3.please send me the Leishmania Case which were recorded in last year.1397
and 1398 by monthly base and health facilities-wise
4.How many vial/Amp have you been requested?
Finally send me the required vial/Amp of Anti Leishmania drug request for
six months

Best regard,

*Dr. Nasir Ahmad Tokhi MD, MPH*| Malaria Project Manager / P4P and
reporting Focal Point | *Just for Afghan Capacity and Knowledge (JACK)*|
Country office Kabul|

Tel: +93(0)705546907 - +93(0)799612015 | dr.tokhi@jack.af | www.jack.af

On Tue, Nov 26, 2019 at 2:50 PM Khairullah Naderi <
khairullahnaderi@gmail.com> wrote:

> Dear Dr. Sahib Tokhi!
>
> Attached please find, anti-leishmaniasis drug request sheet form Kunudz
> for 16 HFs for sex months kindly share with the related department, now
> these days we faces to the shortage of anti-Leishmania in health HFs also
> we have a lot of cases.
>
> BR
> Naderi
>

--000000000000c2627605983de1bb
Content-Type: text/html; charset="UTF-8"
Content-Transfer-Encoding: quoted-printable

<div dir=3D"ltr"><div class=3D"gmail_default" style=3D"font-family:georgia,=
serif;color:#45818e">Dear Khairullah Naderi</div><div class=3D"gmail_defaul=
t" style=3D"font-family:georgia,serif;color:#45818e">Thank you for you requ=
est below point is import to be clear .</div><div class=3D"gmail_default" s=
tyle=3D"font-family:georgia,serif;color:#45818e">1. clarify the closing bal=
ance of Anti Malaria Vial/Amp in the last month of=C2=A0 the year health fa=
cilities wise and stock buffer ?</div><div class=3D"gmail_default" style=3D=
"font-family:georgia,serif;color:#45818e">2.Number of Supplied of Anti Leis=
hmania Vial/Amp (new supplied)</div><div class=3D"gmail_default" style=3D"f=
ont-family:georgia,serif;color:#45818e">3.please send me the Leishmania Cas=
e which were recorded in last year.1397 and 1398 by monthly base and health=
 facilities-wise</div><div class=3D"gmail_default" style=3D"font-family:geo=
rgia,serif;color:#45818e">4.How many vial/Amp have you been requested?</div=
><div class=3D"gmail_default" style=3D"font-family:georgia,serif;color:#458=
18e">Finally=C2=A0send me the required vial/Amp of Anti Leishmania drug req=
uest for six months</div><div><div dir=3D"ltr" class=3D"gmail_signature" da=
ta-smartmail=3D"gmail_signature"><div dir=3D"ltr"><div><div dir=3D"ltr"><di=
v><div dir=3D"ltr"><div><div dir=3D"ltr"><p class=3D"MsoNormal"><span style=
=3D"color:rgb(31,73,125)">Best regard,<u></u><u></u></span></p><p class=3D"=
MsoNormal"><u></u></p><table align=3D"left" cellspacing=3D"0" cellpadding=
=3D"0"><tbody><tr><td width=3D"1" height=3D"12"></td></tr><tr><td></td><td>=
<img src=3D"cid:image003.png@01D502D3.D8F2E650"></td></tr></tbody></table><=
p class=3D"MsoNormal"><b><span style=3D"color:rgb(31,73,125);font-family:&q=
uot;Calibri Light&quot;,sans-serif;font-size:10.5pt"><br><br></span></b></p=
><p class=3D"MsoNormal"><b><span style=3D"color:rgb(31,73,125);font-family:=
&quot;Calibri Light&quot;,sans-serif;font-size:10.5pt"><br></span></b></p><=
p class=3D"MsoNormal"><b><span style=3D"color:rgb(31,73,125);font-family:&q=
uot;Calibri Light&quot;,sans-serif;font-size:10.5pt">Dr. Nasir Ahmad Tokhi =
MD, MPH</span></b><span style=3D"color:rgb(31,73,125);font-size:10pt">| Mal=
aria Project Manager / P4P and reporting Focal Point | </span><b><span styl=
e=3D"color:rgb(46,16,176);font-size:10pt">Just for Afghan Capacity and Know=
ledge (JACK)</span></b><span style=3D"color:rgb(31,73,125);font-size:10pt">=
| Country office Kabul</span><span style=3D"color:rgb(31,73,125)">|<span></=
span></span></p>

<p class=3D"MsoNormal"><span style=3D"color:rgb(31,73,125)">Tel: +93(0)7055=
46907 - +93(0)799612015 | </span><a href=3D"mailto:dr.tokhi@jack.af" target=
=3D"_blank">dr.tokhi@jack.af</a><span style=3D"color:rgb(31,73,125)"> | </s=
pan><a href=3D"http://www.jack.af" target=3D"_blank">www.jack.af</a><span s=
tyle=3D"color:rgb(31,73,125)"> </span><span style=3D"color:rgb(31,73,125)">=
<span></span></span></p></div></div></div></div></div></div></div></div></d=
iv><br></div><br><div class=3D"gmail_quote"><div dir=3D"ltr" class=3D"gmail=
_attr">On Tue, Nov 26, 2019 at 2:50 PM Khairullah Naderi &lt;<a href=3D"mai=
lto:khairullahnaderi@gmail.com">khairullahnaderi@gmail.com</a>&gt; wrote:<b=
r></div><blockquote class=3D"gmail_quote" style=3D"margin:0px 0px 0px 0.8ex=
;border-left:1px solid rgb(204,204,204);padding-left:1ex"><div dir=3D"ltr">=
Dear Dr. Sahib Tokhi!<div><br></div><div>Attached=C2=A0please find, anti-le=
ishmaniasis drug request sheet form=C2=A0Kunudz for 16 HFs for sex months k=
indly share with the related department, now these days we faces to the sho=
rtage of anti-Leishmania in health HFs also we have a lot of cases.</div><d=
iv><br></div><div>BR</div><div>Naderi</div></div>
</blockquote></div>

--000000000000c2627605983de1bb--
--000000000000c2627805983de1bc
Content-Type: image/png; name="image003.png"
Content-Disposition: inline; filename="image003.png"
Content-Transfer-Encoding: base64
Content-ID: <>
X-Attachment-Id:
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--000000000000c2627805983de1bc--